scientific and microscope

Our clinical studies

We are committed to make our Clinical trials Information and Results accessible and transparent while maintaining participants privacy.

 

Clinical studies

This site provides information on both ongoing and completed clinical trials sponsored by Pierre Fabre since 2004. Real-world evidence studies which began after 01 January 2020 are also accessible.

 

Total studies

0

Current studies

0

Oncology

0

Dermatology

0

Rare diseases

0

Others

0
Show more filters
Title Therapeutic area Phase Status Start date (Planned) End date

Phase III study of Vinflunine plus Capecitabine versus Capecitabine alone in patients with advanced breast cancer

Oncology Phase III Completed September 2013 July 2017

Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma

Respiratory Phase II Completed September 2013 April 2014

Efficacy and safety study of F373280 for maintenance of sinus rhythm after electrical cardioversion in patients with persistent Atrial Fibrillation and Chronic Heart Failure

Cardiovascular Phase II Completed May 2013 June 2017

Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia

Oncology Phase I / II Early termination April 2013 March 2017

Emollients in the management of atopic dermatitis in children: prevention of flares

Dermatology Phase III Completed February 2013 February 2014

Study of efficacy and safety of V0498 versus placebo in acute sore throat pain

Respiratory Phase III Completed February 2013 June 2013

Clinical and biophysics evaluation of the cutaneous modifications following the local use of a lotion containing 0,1 % of trétinoïne

Dermatology Phase IV Completed February 2013 February 2014

Randomised phase II trial of oral vinorelbine and cisplatin followed by maintenance with single agent oral vinorelbine versus gemcitabine and cisplatin followed by maintenance with single agent gemcitabine in first line Locally Advanced or Metastatic Non-Small-Cell Lung Cancer patients with squamous histological type

Oncology Phase II Completed December 01, 2012 May 2017

Phase II trial of oral vinorelbine in Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) positive mutation after failure or resistance to treatment with Tyrosine Kinase Inhibitors (TKI) in first line

Oncology Phase II Completed December 2012 April 2015

Randomised phase II study evaluating, as first-line chemotherapy, weekly oral vinorelbine as a single-agent versus weekly paclitaxel as a single-agent in estrogen receptor positive, HER2 negative patients with advanced breast cancer

Oncology Phase II Completed October 2012 September 2018

Effect of V0251 in acute vertigo. A randomized double blind placebo conrolled study

Central Nervous System Phase II Completed June 2012 April 2013

Effect of 3-month treatment with F2695 (75mg OD) on improving functional recovery of patients with ischemic stroke. A multicenter, randomised, double-blind, parallel-group, placebo-controlled study

Cardiovascular Phase II Completed June 2012 February 2015

Exploratory study of L.S.E.S.r. (PERMIXON® 160 mg hard capsule) versus Tamsulosine LP activity on inflammation biomarkers in the treatment of urinary symptoms related to BPH, A multinational, multicen...

Urology Phase IV Completed June 2012 October 2013

Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 309 F0)

Oncology Phase III Completed April 2012 November 2018

A randomised, double blind, controlled, multicentre study in infants with infantile hemangioma to compare propranolol gel to placebo

Dermatology Phase II Completed February 10, 2012 May 09, 2013

Analgesic profile of 3 new Ibuprofen lozenges (V0498TA01A 15mg, 25mg,

Central Nervous System Phase II Completed February 2012 November 2012

Efficacy of the V0034CR01B emollient on xerosis in children with atopic dermatitis. Randomised, vehicle-controlled, parallel-groups, double-blind study with an open label extension

Dermatology Phase III Completed November 2011 May 2012

Urodynamic effect of one single vaginal application of 2 mL of V0162 gel (0.8%) in post-menopausal women with overactive bladder

Urology Phase II Completed July 2011 October 2011

Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract

Oncology Phase II Completed June 2011 February 2015

V0251 oral suspension efficacy and tolerance in vestibular neuritis. A randomised double-blind placebo controlled study

Central Nervous System Phase II Completed May 2011 April 2012

Get access to Partner's pivotal studies supporting our authorized drugs in Europe

Results from pivotal studies conducted by our partners and supporting a marketing approval for whom Pierre Fabre is the holder in Europe are shared below:

 

Melanoma

SPONSOR: PFIZER

Breast cancer 

SPONSOR: PUMA BIOTECHNOLOGY

Colorectal cancer

SPONSOR: PFIZER

Post-transplantation lymphoproliferative disease EBV+

SPONSOR: ATARA